Beike Biotech has once again demonstrated its positive contribution in the construction of industry standardization recently. On April 11, 2024, the National Group Standards Information Platform announced that the “General Requirements for Human Cell Storage Services” (No. T/CRHA 041-2024), which was prepared with the participation of Shenzhen Beike Biotechnology Co., Ltd., was officially released. This group standard document is under the jurisdiction of the Chinese Research Hospital Association and will be implemented from April 15, 2024.
T/CRHA 041-2024 “General Requirements for Human-derived Cell Storage Services” This document stipulates the service providers, service guarantees, service specifications, service provision specifications, service quality control specifications, and service quality supervision, evaluation and improvement requirements for human-derived cell storage services. It is applicable to the management of institutions or departments that provide human-derived cell storage services. It is not applicable to the management of storage service institutions or departments such as hematopoietic stem cells, germ cells, tissue-like tissues composed of cells, and organoid products for blood transfusion or transplantation.
Beike Biotechnology, as one of the participating units of the standard, has been deeply involved in the drafting, research and formulation of the standard. The company relies on its rich experience in cell preparation, storage and clinical transformation over the years to provide important technical support and practical reference for the formulation of standards. As a national high-tech enterprise specializing in the clinical transformation and technical services of biotherapeutic technologies in strategic emerging industries, Beike Biotech always adheres to innovation leadership and actively promotes the construction of standardization work in the cell industry. It has participated in dozens of national standards, local standards, group standards and other standards, covering multiple fields of the cell industry, and has contributed to the high-quality development of my country’s cell industry.
The release of T/CRHA 041-2024 “General Requirements for Human-derived Cell Storage Services” will not only help standardize the human-derived cell storage service market and improve service quality, but will also help promote the healthy development of the entire cell therapy industry. As an important participant and promoter of the industry, Beike Biotech will continue to leverage its technological advantages and innovation capabilities to contribute more wisdom and strength to the standardization construction and development of the industry.